Table 2.
Over survival | Log-Rank | P | ||
---|---|---|---|---|
95%CI | ||||
Gender | ||||
Male | 41.495 | 38.549–44.441 | 1.252 | 0.263 |
Female | 43.367 | 38.680–48.054 | ||
Age | ||||
<65 | 42.890 | 39.884–45.896 | 0.847 | 0.357 |
≥65 | 40.708 | 36.298–45.118 | ||
Mucinous cancer | ||||
Yes | 40.778 | 40.292–45.872 | 2.676 | 0.102 |
No | 43.082 | 40.292 | 45.872 | |
Tumor grade | ||||
Moderately + well | 48.877 | 44.743–53.012 | 0.632 | 0.427 |
Poorly | 41.239 | 38.264–44.213 | ||
T stage | ||||
1 | 56.368 | 54.423–58.214 | 31.124 | <0.001 |
2 | 54.000 | 51.510–56.490 | ||
3 | 39.296 | 35.677–42.896 | ||
4 | 29.073 | 22.357–35.788 | ||
N stage | ||||
<1 | 53.854 | 51.555–56.154 | 23.160 | <0.001 |
≥1 | 37.034 | 33.734–40.33 | ||
Signet ring cell carcinoma | ||||
No | 45.442 | 42.553–48.331 | 3.979 | 0.046 |
Yes | 35.640 | 30.714–40.567 | ||
LVI | ||||
Positive | 38.679 | 35.168–42.190 | 6.230 | 0.013 |
Negative | 48.205 | 45.063–51.347 | ||
Nerve invasion | ||||
Positive | 33.648 | 30.014–37.281 | 27.814 | <0.001 |
Negative | 52.007 | 49.232–54.782 |